Articles from Belhaven Biopharma

Belhaven Announces Significant Expansion of Nasdepi Patent Portfolio, Commercial Supply Readiness, and FDA Alignment on Key Topics
Pivotal Clinical Study Poised to Start in Q3 2026
By Belhaven Biopharma · Via ACCESS Newswire · July 16, 2026
Articles from Belhaven Biopharma | Hannibal Courier - Post